Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oric Pharmaceuticals (ORIC) Free Cash Flow (2019 - 2026)

Oric Pharmaceuticals filings provide 8 years of Free Cash Flow readings, the most recent being -$32.4 million for Q1 2026.

  • Quarterly Free Cash Flow rose 1.46% to -$32.4 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$111.2 million through Mar 2026, up 4.44% year-over-year, with the annual reading at -$111.7 million for FY2025, 1.9% up from the prior year.
  • Free Cash Flow hit -$32.4 million in Q1 2026 for Oric Pharmaceuticals, down from -$22.7 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at -$15.6 million in Q4 2022 and bottomed at -$32.9 million in Q1 2025.
  • Average Free Cash Flow over 5 years is -$24.8 million, with a median of -$24.3 million recorded in 2023.
  • The largest annual shift saw Free Cash Flow crashed 59.36% in 2022 before it increased 19.68% in 2025.
  • Oric Pharmaceuticals' Free Cash Flow stood at -$15.6 million in 2022, then plummeted by 55.78% to -$24.3 million in 2023, then fell by 16.22% to -$28.3 million in 2024, then increased by 19.68% to -$22.7 million in 2025, then tumbled by 42.84% to -$32.4 million in 2026.
  • Per Business Quant, the three most recent readings for ORIC's Free Cash Flow are -$32.4 million (Q1 2026), -$22.7 million (Q4 2025), and -$25.1 million (Q3 2025).